Antioxidant response element (ARE) and nuclear transcription factor Nrf2 are known to regulate expression and coordinated induction of NQO1 and other detoxifying enzyme genes in response to antioxidants and xenobiotics. A cytosolic inhibitor of Nrf2, 
Introduction
NAD(P)H:quinone oxidoreductases (NQO1 and NQO2) are¯avoproteins that catalyze two-electron reduction and detoxi®cation of quinones and their derivatives (Radjendirane et al., 1997; Talalay et al., 1995) . This protects cells against quinones induced oxidative stress and neoplasia. NQO17/7 mice lacking NQO1 protein demonstrate increased sensitivity to benzo(a)pyrene induced carcinogenesis, as compared with wild type mice . Transcription of the NQO1 gene is activated in response to xenobiotics (e.g., b-naphtho¯avone (b-NF)); antioxidants (e.g., tert-butylhydroquinone (t-BHQ)) and oxidants (e.g., hydrogen peroxide) (Radjendirane et al., 1997; Talalay et al., 1995; Rushmore and Pickett, 1993) . Interestingly, NQO1 is part of a cellular defense mechanism that is responsible for the induction of more than two dozen genes in response to electrophilic and/or oxidative stress (Radjendirane et al., 1997; Talalay et al., 1995) . The genes that are coordinately induced with the NQO1 include glutathione Stransferases (GSTs), which conjugate hydrophobic electrophiles and ROS with glutathione (Rushmore and Pickett, 1993) ; g-glutamylcysteine synthetase (g-GCS), which plays a role in the glutathione metabolism (Mulkahy et al., 1997) ; ferritin-L gene, which plays an important role in iron storage (Wasserman and Fahl, 1997) ; and heme oxygenase-1 (HO-1), which catalyzes the ®rst and rate-limiting step in heme catabolism (Choi and Alam, 1996) . The coordinated induction of these genes, including NQO1, protects cells against free radical damage, oxidative stress and neoplasia. This is critical in achieving chemoprevention (Radjendirane et al., 1997; Talalay et al., 1995; Rushmore and Pickett, 1993) .
Antioxidant response element (ARE) found in the promoter of NQO1 and other detoxifying enzyme genes regulate basal expression and coordinated induction of these genes in response to xenobiotics and antioxidants (Radjendirane et al., 1997; Talalay et al., 1995; Rushmore and Pickett, 1993) . Nuclear transcription factors Nrf2 and Nrf1 bind to the ARE and mediate ARE-regulated expression and induction of NQO1 and other detoxifying enzyme genes (Venugopal and Jaiswal, 1996; Nguyen et al., 2000; Wild et al., 1999; Alam et al., 1999) . Nrf2 and Nrf1 are b-zip (leucine zipper) proteins that do not heterodimerize with each other and require another leucine zipper protein to be active (Venugopal and Jaiswal, 1998; Chan et al., 1993; Moi et al., 1994) . Recently, Nrf3, a third member of the Nrf family of transcription factors, was cloned and sequenced (Kobayashi et al., 1999) . However, the role of Nrf3 in the regulation of ARE-mediated expression and induction of detoxifying enzyme genes remains unknown. Recent studies from our laboratory have shown that Nrf2 and Nrf1 heterodimerize with c-Jun and bind to ARE (Venugopal and Jaiswal, 1998) . This binding, however, required unknown cytosolic factors (Venugopal and Jaiswal, 1998) .
In the present study, we describe the isolation and functional characterization of a cytosolic factor INrf2. INrf2 retains Nrf2 in the cytosol leading to the repression of ARE-mediated NQO1 gene expression. Treatment of cells with antioxidants and xenobiotics releases Nrf2 from INrf2. Nrf2 moves to the nucleus leaving behind INrf2 in the cytosol. Deletion mapping of INrf2 identi®ed KELCH domain and C-terminal region as the required elements for retention of Nrf2 in the cytosol. Interestingly, both KELCH domain and Cterminal region independently retained Nrf2 in the cytosol leading to the repression of ARE-mediated NQO1 gene expression. Antioxidants and xenobiotics treatment released the Nrf2 in both these cases resulting in nuclear translocation of Nrf2 and induction of ARE-mediated NQO1 gene expression. Northern analysis indicated that Nrf2 and INrf2 transcription do not change in Hep-G2 cells upon treatment with antioxidants and xenobiotics. Figure  1a . Nrf2 is a Cap`n' Collar (CNC) containing b-zip protein. Other domains of Nrf2 include hydrophobic region (H), transcriptional activation (TA) region rich in acidic residues and basic/leucine zipper region for heterodimerization and binding to the DNA (Chan et al., 1993; Moi et al., 1994) . The basic/leucine zipper region of Nrf2 is highly conserved in Nrf1 and Nrf3 (Chan et al., 1993; Moi et al., 1994; Kobayashi et al., 1999) . The full length Nrf2 (Figure 1a ) was used as bait to isolate and clone rat liver INrf2, a cytosolic inhibitor of Nrf2 (Figure 1b ± d) . The nucleotide sequence of INrf2 is shown in Figure 1b . The cDNA deduced amino acid sequence of INrf2 is shown in Figure 1c . INrf2 is a 624 amino acids (MW=*70 kDa) protein.
Results

Nrf2 and its functional domains are shown in
INrf2 is a cysteine rich protein. Analysis of the INrf2 amino acid sequence revealed a BTB (broad complex, tramtrack, bric-a-brac)/POZ (poxvirus, zinc ®nger) domain and a KELCH domain (Figure 1d ). Genbank analysis of INrf2 protein sequence revealed 97% identity with Mouse Keap1 protein (Genbank Accession #BAA34639) and 93% identity with Human Kelch-like ECH-associated protein 1 (Genbank Accession #BAA09481). Because of this very high sequence identity, we believe that these proteins are cross-species homologues. The BTB/POZ and KELCH domains and the 25 cysteine residues in the rat INrf2 were found conserved in mouse and human INrf2/Keap1 (data not shown).
Initial analysis of rat hepatoma (H4II), human hepatoblastoma (Hep-G2) and quail ®broblast (QT6) indicated that INrf2 expression was highest in H4II and lowest in QT6 cells (data not shown). Therefore, we selected QT6 cells for over expression of INrf2 to study its structure function relationship and role in AREmediated NQO1 gene regulation. Immunoprecipitation of transfected QT6 cells overexpressing INrf2-V5 with V5 antibody resulted in precipitation of a complex that contained INrf2-V5 and Nrf2 indicating an in vivo interaction between INrf2 and Nrf2 (Figure 2a ). In the same experiment, preimmune serum failed to precipitate INrf2 or Nrf2. Similar results were also observed with in vitro translated Nrf2-V5 and INrf2. The in vitro translated Nrf2-V5, INrf2 and luciferase are shown in Figure 2b . In vitro translated Nrf2-V5 was incubated with INrf2 or luciferase and immunoprecipitated with V5 antibody. The results are shown in Figure 2c . V5 antibody immunoprecipitated Nrf2-V5 complexed with INrf2 but not with luciferase.
The cDNA encoding Nrf2 was subcloned in the enhanced green¯uorescence protein vector pEGFP to produce pEGFP-Nrf2 plasmid. This plasmid upon transfection in QT6 cells, expressed EGFP tagged (Figures 3d and 4e ). This indicates that INrf2, produced from pcDNA-INrf2, retained the EGFP-Nrf2 in the cytoplasm. When QT6 cells, co-transfected with pEGFP-Nrf2 and pcDNAINrf2, were treated with t-BHQ dissolved in DMSO, Nrf2 was localized in the nucleus (Figure 3f ). This indicated that t-BHQ treatment released the EGFPNrf2 from INrf2 that moved to the nucleus (Figure 3f ). Similar results were also observed with b-NF treatment (Figure 3g ). In addition to nuclear translocation studies, the over expression of INrf2 in QT6 cells, led to INrf2 concentration dependent repression of the Nrf2-regulated NQO1 gene hARE-mediated luciferase gene expression (Figure 4 ). The treatment of QT6 cells expressing endogenous and cDNA derived INrf2 with t-BHQ led to increased expression of NQO1 gene hARE-mediated luciferase gene expression (Figure 4) . The induced levels of NQO1 gene hARE-mediated luciferase gene expression were more or less similar in QT6 cells expressing endogenous levels of INrf2 and cells overexpressing INrf2 (Figure 4) . Similar experiments as described above for QT6 cells were also performed in rat hepatoma (H4II) and human hepatoblastoma (HepG2) cells that contain higher levels of INrf2 as compared with QT6 cells. The results indicated that basal ARE-mediated luciferase activity was lower in H4II and Hep-G2 cells as compared to QT6 cells (data not shown). This was presumably due to higher abundance of INrf2 in H4II
and Hep-G2 cells than QT6 cells. However, once induced with tBHQ, the ARE-mediated luciferase activity was induced to the same level in H4II and and t-BHQ resulted in signi®cant increase in both transcripts of NQO1 RNA (generated due to two dierent polyadenylation sites). However, the transcription of Nrf2 and INrf2 remained more or less unaected due to treatment of Hep-G2 cells with b-NF and t-BHQ.
A model is presented in Figure 10 that demonstrates the mechanism of signal transduction from antioxidants and xenobiotics to the ARE that regulates basal expression and induction of NQO1 and other detoxifying enzyme genes.
Discussion
Exposure of cells to antioxidants and xenobiotics leads to the ARE-mediated increase of a battery of genes including NQO1 (Radjendirane et al., 1997; Talalay et al., 1995; Rushmore and Pickett, 1993) . This induction is important in protection of cells against oxidative stress and neoplasia. Nrf2 is known to bind with ARE and activate NQO1 and other detoxifying enzyme genes (Venugopal and Jaiswal, 1996; Nguyen et al., 2000; Wild et al., 1999; Alam et al., 1999) .
In the present study, we have cloned INrf2, a cytosolic inhibitor of Nrf2. The amino acid sequence analysis of INrf2 revealed the presence of two domains that are conserved in other actin binding proteins (Albagli et al., 1995; Kim et al., 1999) . These included a BTB/POZ domain in the N-terminal region and Kelch/DGR domain in the C-terminal region of INrf2. (Itoh et al., 1999) . Mouse Keap1 was shown to retain Nrf2 in the cytoplasm and treatment of cells with diethylmaleate (DEM) resulted in the release of Nrf2 that translocated to nucleus (Itoh et al., 1999) . It may be noteworthy (Marini et al., 1997) . On contrary, Nrf2-small Maf are shown to repress ARE-mediated NQO1, GST Ya and g-GCS genes expression and induction in response to antioxidants and xenobiotics Wild et al., 1999; . In addition, antioxidants (t-BHQ) and xenobiotics (b-NF) increase ARE-mediated but not MARE-mediated gene expression (Dhakshinamoorthy and Jaiswal, unpublished) . Therefore, in essence, this is the ®rst report that Deletion mapping of INrf2 and immunoprecipitation, nuclear translocation and NQO1 gene hAREluciferase assays indicated that KELCH domain (amino acid residues 361 ± 597) and C-terminal region (amino acid residues 598 ± 624) of INrf2 independently interacted with Nrf2. Both these interactions resulted in retention of EGFP-Nrf2 in the cytosol and repression of NQO1 gene hARE-mediated luciferase gene expression in transfected cells. The treatment of cells with t-BHQ resulted in the release of EGFP-Nrf2 from INrf2 and localization of EGFP-Nrf2 in the nucleus leading to the induction of NQO1 gene expression. The mechanism of independent interaction of two dierent domains of INrf2 with Nrf2 remains unknown. A comparison of amino acid sequences of Cterminal region (598 ± 624) of rat INrf2 cloned in the present studies with previously cloned human and mouse Keap1/INrf2 indicated 100% conservation (present study and Itoh et al., 1999) . The NCBI CD structure analysis of rat INrf2 showed presence of ®ve Kelch motifs in KELCH domain of INrf2. Each of these motif is about 50 amino acids in length and rich in glycine residues. An analysis of 27 amino acids in the C-terminal region of INrf2 also indicated presence of glycine residues. Therefore, glycine residues in KELCH and C-terminal region of INrf2 may be important for interaction with Nrf2. The above results also indicate that each of the Kelch motif in the KELCH domain of INrf2 may retain Nrf2 independent of other Kelch motifs, as observed with C-terminal region of INrf2 leading to the repression of hAREmediated NQO1 gene expression. If found true, it will mean that INrf2 contains 5 Kelch motifs and one Cterminal region that interact with Nrf2 independent of each other and repress hARE-mediated NQO1 gene expression. These results will also indicate that several regions of INrf2 binds with a single molecule of Nrf2 or several molecules of Nrf2 bind to a single molecule of INrf2. We prefer the later hypothesis, since it is known that only 73 amino acids from the N-terminus of Nrf2 (Neh2 domain) binds to INrf2 (Itoh et al., 1999) . These predictions, however, remains to be determined by further experiments.
The mechanism of signal transduction, from xenobiotics and antioxidants to the INrf2 and Nrf2 proteins, is complex and remains largely unknown. A model to show the various steps of signal transduction, from xenobiotics and antioxidants to the ARE, is shown in Figure 10 . Xenobiotics and antioxidants undergo metabolism to generate electrophiles and superoxide (ROS) (De Long et al., 1987) . The superoxide/electrophile signal presumably passes through known and unknown intermediary proteins, to Nrf2, Nrf1 and c-Jun, which bind to the ARE and activate NQO1 and other detoxifying enzyme genes Jaiswal, 1996, 1998) . Nrf2 is retained in the cytoplasm by a cytosolic inhibitor, INrf2, under normal conditions. Treatment of cells with antioxidants and xenobiotics releases Nrf2 from INrf2. Nrf2 translocates to the nucleus and forms heterodimers with c-Jun. Nrf2 heterodimerization with c-Jun requires unknown cytosolic factors (Venugopal and Jaiswal, 1998) . Therefore, INrf2, Nrf2 and/or c-Jun may function as oxidative sensors within the cells and play very signi®cant role in activation of cellular defenses by activating a battery of chemopreventive genes. The transcription of c-Jun is activated in response to b-NF and t-BHQ (Radjendirane and Jaiswal, 1999; Bergelson et al., 1994; Puga et al., 1992; Wild et al., 1998) . However, the transcription of INrf2 and Nrf2 do not change in response to xenobiotics and antioxidants (Figure 9 ). Therefore, it is more likely that INrf2 and/or Nrf2 are modi®ed in response to xenobiotics and antioxidants than c-Jun. However, the possibility of c-Jun modi®cation, by xenobiotic and antioxidant induced mechanisms, cannot be ruled out. Nrf1 is expected to function in a similar manner as Nrf2. Jun-B and Jun-D are expected to function similar to c-Jun. This is because of their role in ARE-mediated expression and induction of the NQO1 gene (Venugopal and Jaiswal, 1998; Li and Jaiswal, 1992; Jaiswal, 1999) . The overall mechanism of signal transduction, from antioxidants and xenobiotics to Nrf and Jun proteins, may also involve many intermediary steps that also remain unknown. The major mechanisms of modi®cation in the regulation of gene transcription include phosphorylation/dephosphorylation and redox regulation (Hunter and Karin, 1992; Bauer et al., 1999) . INrf2, Nrf2 and c-Jun contain several potential phosphorylation/ dephosphorylation and redox regulation sites that are conserved across species (Dhakshinamoorthy and Jaiswal, 2001 unpublished results) . These sites include protein kinase C (PKC), tyrosine kinase (TYR), casein kinase II (CK2) and cysteine residues. In addition, several reports have demonstrated that ARE-mediated regulation of gene expression is sensitive to kinase inhibitors and redox modulators (Yu et al., 2000a,b; Huang et al., 2000; Li and Jaiswal, 1994) . Hence, phosphorylation/dephosphorylation and/or redox regulation may play a role in the modi®cation of INrf2, Nrf2 and/or c-Jun.
In conclusion, we have cloned and sequenced rat INrf2, a cytosolic inhibitor of Nrf2. INrf2 retains Nrf2 in the cytosol resulting in the repression of AREmediated NQO1 gene expression. Antioxidants and xenobiotics antagonize this inhibition leading to the release of Nrf2 from INrf2. Nrf2 translocates in the nucleus leaving behind the INrf2 in the cytosol. This results in the induction of ARE-mediated NQO1 gene expression. The KELCH domain containing Kelch motifs and C-terminal region of INrf2, both rich in glycine, independently retained Nrf2 in the cytosol. The Nrf2 dissociated from INrf2 domains in response to antioxidants and xenobiotics. This resulted in nuclear localization of Nrf2 and induction of NQO1 gene expression. The transcription of INrf2 and Nrf2 did not change in response to xenobiotics and antioxidants indicating that they may be post-transcriptionally modi®ed for the release of Nrf2 from INrf2.
Materials and methods
Materials
The enzymes used in this study were purchased from Life Technologies GIBCO BRL, (Rockville, MD, USA). The plasmid pcDNA3.1/V-5-His-TOPO and Anti-V5 Antibody were purchased from Invitrogen (Carlsbad, CA, USA). The plasmids pEGFPC1 was purchased from Clontech Laboratories (Palo Alto, CA, USA). DMEM and MEM were purchased from Life Technologies GIBCO BRL. Eectene Transfection Reagent was purchased from Qiagen (Valencia, CA, USA). The Nrf2 antibodies were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA). t-BHQ and all other chemicals were purchased from Sigma (St. Louis, MO, USA). The pGL2 promoter plasmid containing ®re¯y luciferase gene, internal control plasmid pRL-TK that encodes Renilla luciferase, the dual luciferase kit and the TNT T7/T3 coupled rabbit reticulocyte lysate system were obtained from Promega (Madison, WI, USA). The Rat liver Marathon ready cDNA library was obtained from Clontech Laboratories Inc. The Rat liver l cDNA library was obtained from Stratagene (La Jolla, CA, USA). The Hybond ECL nitrocellulose membrane, ECL Western blot analysis kit and Amplify NAMP1000 were purchased from Amersham Pharmacia (Pitscataway, NJ, USA). All the PCR primers used in the study were synthesized at Sigma-Genosys (Houston, TX, USA). The graphical maps of the dierent protein molecules were designed using the Vector NTI software. The various sequence analysis were performed through the website http://www.ncbi.nlm.nih.gov or the Vector NTI software.
Isolation and cloning of cytosolic inhibitor of Nrf2
We used Nrf2 as bait to identify the cytosolic factor(s) that might interact with Nrf2 by procedures previously described (Schmitt et al., 1993; Qiagen, 2000) . Brie¯y, Nrf2 was subcloned into eukaryotic expression vector pcDNA, to generate a pcDNA-Nrf2 plasmid that, upon transfection in human hepatoblastoma (Hep-G2) and rat hepatoma (H4II) cells, produced Nrf2 with a histidine tag (Nrf2-His). Since the expression was signi®cantly higher in H4II cells, as compared to Hep-G2, we decided to use H4II cells for further studies. The pcDNA-Nrf2 plasmid was transfected in H4II cells to overexpress the Nrf2-His fusion protein. The cytosolic extract from transfected H4II cells were passed through a nickel column and proteins bound to the nickel column were eluted and analysed by SDS ± PAGE. This identi®ed three distinct proteins that bound to Nrf2. We focused on a major protein band of molecular weight 70 kDa that interacted with Nrf2. This protein was digested with lys-C in the gel and the digested peptides were separated on reverse phase HPLC. The two internal peptides were sequenced. The degenerated oligonucleotides, designed from the peptide sequences, and a rat liver Marathon ready cDNA library were used in a PCR reaction to isolate 800 base pairs of the cDNA encoding a portion of rat cytosolic protein. The 800 base pair cDNA was used as a probe to screen the rat liver lgt11 cDNA library by procedures as described . Full length cDNA clones encoding the rat cytosolic protein were isolated and sequenced. The rat cDNA and protein proved to be homologues of mouse Keap1. Mouse Keap1 was reported to interact with the N-terminal portion of Nrf2 and retain Nrf2 in the cytosol (Itoh et al., 1999) . The rat protein, cloned in our laboratory, was designated as INrf2 (Inhibitor of Nrf2). We believe that the name INrf2 is more appropriate than Keap1 since it is speci®c to Nrf2 and also is in line with other proteins of this nature e.g. IkB, a cytosolic inhibitor of NF-kB (Thanos and Maniatis 1995; SchulzeOstho et al., 1997) .
Plasmid construction
The construction of the NQO1 gene hARE reporter plasmid pGL2-hARE-Luc and expression plasmid pcDNA-Nrf2 are described . The Nrf2 cDNA was also sub-cloned in-frame with the V5 epitope of the pcDNA expression plasmid to generate pcDNA-Nrf2-V5. This plasmid upon transfection in cells encodes V5 tagged Nrf2 protein. The V5 epitope contains 14 amino acids with the sequence: Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-Leu-GlyLeu-Asp-Ser-Thr. Rat INrf2 cDNA encoding the full-length protein was also subcloned in pcDNA vector to generate pcDNA-INrf2 and pcDNA-INrf2-V5 plasmids. Five sets of primers as shown in Table 1 
Cell culture
Quail ®broblasts (QT6) cells were grown as monolayer cultures in 6-well plates at 378C in 95% air and 5% CO 2 in DMEM medium supplemented with 10% FBS, penicillin (40 units/ml) and streptomycin (40 mg/ml). Human hepatoblastoma (Hep-G2) cells were also grown as monolayer cultures in minimal essential medium supplemented with fetal bovine serum and antibiotics under similar conditions as described for QT6 cells.
Immunoprecipitation assay to determine in vivo interaction of INrf2 with Nrf2
The QT6 cells were transfected with pcDNA-INrf2-V5. After 36 h of transfection, the cells were lysed using the lysis buer containing 50 mM HEPES at pH 7.8, 300 mM NaCl, 5 mM EDTA, 1% NP-40, 3 mM dithiothreitol (DTT) and 0.5 mM phenylmethylsulfonyl¯uoride. The cell lysates were pre-cleared as follows. To 1 ml of the whole cell lysate, 0.25 mg of rabbit IgG was added along with 20 ml of resuspended volume of Protein A/G Agarose. The mixture was incubated at 48C for 30 min. Then the agarose beads were pelleted and the supernatant was transferred to a fresh tube. Two micrograms of anti-Nrf2 was added to the supernatant and incubated for 2 h at 48C. Then 20 ml of resuspended volume of Protein A/G Agarose was added and incubated for an additional 3 h. The agarose beads were then pelleted and washed three times with the wash buer (50 mM HEPES at pH 7.8, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 3 mM dithiothreitol (DTT) and 0.5 mM phenylmethylsulfonyl¯uoride). After the ®nal wash, the bound proteins were eluted using the elution buer (50 mM HEPES at pH 7.8, 500 mM NaCl, 5 mM EDTA, 1% NP-40, 3 mM dithiothreitol (DTT) and 0.5 mM phenylmethylsulfonyl¯uoride). The eluted samples were run on a 10% SDS ± PAGE and transferred to the ECL Nitrocellulose membrane. Western blot was probed with the anti-V5 antibody to detect the V5-tagged INrf2 protein. The same membrane was stripped and re-probed with the anti-Nrf2 antibody to demonstrate the presence of Nrf2.
In vitro transcription/translation of INrf2 and Nrf2
The in vitro transcription/translation of the pcDNA plasmids encoding Nrf2, INrf2, INrf2 deletions and luciferase were performed using the TNT Coupled Rabbit Reticulocyte Lysate Systems (Promega) by procedures as suggested in the manufacturer's protocol. Two micrograms of the various plasmids were used for transcription/ translation. Redivue L-[
35 S]-methionine was substituted for methionine in the reactions. After the coupled transcription/translation, the proteins were checked for their correct size on a 10% SDS ± PAGE. Brie¯y, 5 ml of the translated proteins were resolved on a 10% SDS ± PAGE, treated with Amplify solution (NAMP 100, Amersham Pharmacia) to enhance the 35 S signal, dried and exposed to X-ray ®lm.
Immunoprecipitation assay to determine in vitro interaction of INrf2 with Nrf2
The in vitro translated INrf2 and Luciferase (control) were mixed with in vitro translated Nrf2-V5 in equimolar ratios and incubated at 378C for 15 min. The anti-V5 antibody was used to immunoprecipitate Nrf2 and associated proteins by procedures as described above for in vivo interaction of INrf2 with Nrf2. The bound proteins were eluted and run on a 10% SDS ± PAGE. The gel was treated with Amplify solution (NAMP 100, Amersham Pharmacia) to enhance the 35 S signal, dried and exposed to X-ray ®lm.
Transfection and nuclear localization assay
The nuclear localization studies of the EGFP-tagged Nrf2 and EGFP-tagged INrf2 protein molecules were performed in QT6 cells. The QT6 cells were grown on Lab-Tek II Chamber Slides (Nalge Nunc International, Naperville, IL, USA). Half a microgram of plasmids pEGFP-Nrf2, pEGFP-INrf2, pcDNA-INrf2 and INrf2 deletions pcDNAINrf2L1,pcDNA-INrf2L2,pcDNA-INrf2L3,pcDNA-INrf2L4 and pcDNA-INrf2L5 were transfected either alone or in combination using the Eectene Transfection Reagent Kit by procedures as described in manufacturer's protocol. After 36 h of transfection, the cells were washed twice with 1X PBS. Then the chamber was removed from the slide and a cover slip was placed over it. The slide was observed under the ZEISS¯uorescent microscope by excitation at 488 nm, and the images were captured by described procedures (Chan et al., 1999) . The pictures were taken using the Kodak select black and white ®lm on a Nikon UFX camera. For induction studies, the cells were treated Reverse: 5' TCA CAC CTG TAG GTC TGC CAG GCG CAG 3'
